Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Puradelta Lestari Tbk. (DMAS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Puradelta Lestari Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Puradelta Lestari Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T, 40.24M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Puradelta Lestari Tbk. is far larger — about 11.3× UBC Medical Indonesia Tbk.'s market cap, and Puradelta Lestari Tbk. is more actively traded (40.24M versus 817.3K). Which is the better fit depends on your goals.

DMASLABS
Market Cap
6.6T584.6B
Volume
40.24M817.3K
Lot
402.39K8.17K
Turnover
5.52B120.01M
Average Price
137.3146.84
Value
5.52B120.01M
Indicative Equilibrium Price
137146
Indicative Equilibrium Volume
9.27K59

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DMAS
View details
LABS
View details

About Puradelta Lestari Tbk.

PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.

Read more on DMAS

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS